6 special needs drugs combined

6. Neurological Drugs and Psychotropics

💊 First-Line Antiepileptic Drugs

This table outlines the primary first-line medications for various seizure types.

Seizure Type	First-Line Drug(s)
Focal (Partial) Seizures	Carbamazepine
Generalised Tonic-Clonic	Valproate
Absence Seizures	Ethosuximide, Valproate
Myoclonic Seizures	Valproate
Special Consideration¹	Lamotrigine, Levetiracetam

¹ May be considered first-line for focal and generalised tonic-clonic seizures in females of child-bearing potential.

---

⚠️ Adverse Drug Reactions (ADRs) Relevant to Dentistry

Many antiepileptic drugs share side effects that can impact dental treatment. Below are common ADRs and the specific drugs associated with them according to the provided text.

• Drowsiness, Dizziness, and Ataxia (impaired coordination): These are common and can affect patient stability.

  • Drugs causing these include: Barbiturates, Benzodiazepines, Gabapentinoids (Gabapentin, Pregabalin), Carbamazepine, Ethosuximide, Lamotrigine, Levetiracetam, Oxcarbazepine, Phenytoin, Topiramate, and Valproate.

• Dry Mouth (Xerostomia): This increases the risk for dental caries.

  • Drugs causing this include: Benzodiazepines, Gabapentinoids, and Carbamazepine.

• Motor Disturbances: These can interfere with patient cooperation and procedures.

  • Tremor: Caused by Gabapentinoids, Oxcarbazepine, and Valproate.

  • Nystagmus (involuntary eye movements): Caused by Oxcarbazepine, Phenytoin, and Topiramate.

  • Orofacial Dyskinesia (involuntary facial movements): A rare side effect of Carbamazepine.

• Salivary Changes:

  • Hypersalivation (drooling): Can be a paradoxical side effect of Benzodiazepines, potentially complicating restorative work.

• Taste Disturbances: This can be caused by Topiramate.

• Serious Skin Reactions: Rare but severe reactions like Stevens-Johnson Syndrome (SJS) can manifest on the face and oral mucosa.

  • Drugs with this rare risk include: Barbiturates, Gabapentinoids, Carbamazepine, Ethosuximide, Lamotrigine, Levetiracetam, Oxcarbazepine, and Phenytoin.

• Gingival Hyperplasia: A well-known side effect that complicates oral hygiene, specifically associated with Phenytoin.

---

🦷 Key Dental Considerations

• Pharmacological Interactions

  • CNS Depressants: Avoid co-prescribing other CNS depressants, as this can worsen sedation.

  • CYP3A4 Enzyme: Be aware that some antiepileptics (like phenobarbital) are potent inducers of the CYP3A4 enzyme, which can reduce the effectiveness of other drugs, including metronidazole.

• Patient Management

  • Chair Positioning: Due to common side effects like drowsiness and dizziness, always provide assistance to patients when they are moving into or out of the dental chair.

  • Appointment Timing: It is best to schedule appointments when the patient’s medication levels are most optimal to reduce the risk of a seizure.

  • Procedural Aids: For patients with motor disturbances like tremors, procedural difficulty can be anticipated for tasks like taking radiographs. For hypersalivation, the use of a rubber dam is recommended to maintain a dry field for restorations.

.

Quick Reference: Parkinson’s Disease Drugs in Dentistry

Drug Class	Example Drugs (Brand Name)	Key Dental ADRs	Dental Management & Considerations
Dopamine Agonists	• Apomorphine (Movapo) • Pramipexole (Sifrol) • Bromocriptine (Parlodel)	• Orthostatic hypotension • Dyskinesia (involuntary movements) • Impulse control disorders (e.g., binge eating, compulsive spending) • Drowsiness	• Reposition the dental chair slowly to prevent fainting. • Be aware that binge eating can increase caries risk. • Interactions with CYP3A4 inhibitors (e.g., erythromycin, fluconazole) may increase ADRs or prolong QT interval.
Anticholinergics	• Benzatropine (Benztrop) • Trihexyphenidyl (Artane)	• Dry mouth (Xerostomia) • Orthostatic hypotension • Dyskinesia • Drowsiness	• Manage dry mouth to reduce the risk of caries and mucosal irritation. • Reposition the patient slowly. • No significant dental drug interactions are noted.
MAO-B Inhibitors	• Rasagiline (Azilect) • Selegiline (Eldepryl)	• Orthostatic hypotension • Dyskinesia (can make it hard for patients to remain still)	• Reposition the patient slowly. • Involuntary movements may complicate procedures; consider shorter appointments. • No significant dental drug interactions are noted.
Other PD Drugs	• Levodopa/carbidopa (Kinson) • Entacapone (Comtan) • Amantadine (Symmetrel)	• Dry mouth (Amantadine, Entacapone, Opicapone) • Orthostatic hypotension • Dyskinesia • Impulse control disorder (Levodopa combos)	• Manage dry mouth as a priority. • Advise patients to take Levodopa 1 hour before the procedure to minimize tremor and rigidity. • Caution with Adrenaline: Entacapone may increase the risk of tachycardia; use proper LA technique.

Of course. Here is the summary of Alzheimer’s disease drugs presented in a document format.

Summary of Alzheimer’s Disease Drugs for Dental Practice

This summary outlines the key pharmacological agents used for Alzheimer’s disease and their specific implications for dental practice, based on the provided lecture notes.

---

🧠 Anticholinesterases

Anticholinesterase drugs are used in early-stage Alzheimer’s disease to increase the availability of acetylcholine in the brain by reducing its breakdown.

• Example Drugs: Donepezil (Arazil, Aricept), Galantamine (Galantyl, Reminyl), and Rivastigmine (Exelon).

• Adverse Drug Reactions (ADRs): Common side effects relevant to the dental setting include drowsiness, dizziness, tremor, increased sweating, hypertension, and fainting.

• Dental Management & Considerations:

  • The risk of dizziness and fainting can complicate patient positioning and their ability to tolerate treatment.

  • Drug interactions are a key concern. CYP3A4 inhibitors like erythromycin or fluconazole should be avoided if possible.

  • Specifically with galantamine, caution is required when prescribing medications known to prolong the QT interval, such as clarithromycin, erythromycin, and fluconazole.

---

🧠 NMDA Antagonists

N-methyl-D-aspartate (NMDA) antagonists work by blocking NMDA receptors to prevent neuronal damage caused by excessive glutamate stimulation.

• Example Drug: Memantine (Ebixa, Memanxa).

• Adverse Drug Reactions (ADRs): Common side effects include confusion, dizziness, drowsiness, headache, agitation, and hallucinations. Anxiety is an infrequent side effect.

• Dental Management & Considerations:

  • Side effects like confusion, agitation, and hallucinations can severely complicate communication and patient cooperation during dental procedures.

  • Management strategies include using calm communication, providing clear and simple instructions, scheduling shorter appointments, and involving a familiar caregiver to help reduce the patient’s anxiety.

---

Overall Patient Management

When treating any patient with Alzheimer’s disease, regardless of their specific medication, two factors are critical:

• Cognitive Assessment: The dentist must recognize and assess the patient’s level of cognitive decline before proceeding with treatment.

• Informed Consent: It is essential to ensure valid consent is obtained. Depending on the patient’s cognitive state, this may require the involvement of a caregiver or legal power of attorney.

Revised Summary of Antidepressants for Dental Practice

This summary outlines the key classes of antidepressant medications, explicitly linking their side effects and dental implications to the specific drugs responsible, based on the provided lecture notes.

---

Indications and General Adverse Effects

• Indications: Antidepressants are prescribed for major depression, anxiety disorders, and some eating disorders.

• General Concerns:

  • Serotonin Toxicity: A risk when antidepressants are co-prescribed with certain drugs, notably tramadol.

  • Withdrawal Effects: Discontinuing these medications can cause nausea, anxiety, and tremor.

---

Antidepressant Drug Classes and Their Side Effects

Monoamine Oxidase Inhibitors (MAOIs)

• Adverse Effects: MAOIs can cause orthostatic hypotension, headache, drowsiness, tremor, dizziness, and dry mouth.

• Dental Implications:

  • The effects of adrenaline may be increased in patients taking MAOIs.

  • Tramadol is contraindicated with MAOIs due to the risk of serotonin toxicity.

Selective Serotonin Reuptake Inhibitors (SSRIs)

• Example Drugs: Citalopram (Celapram), Fluoxetine (Zactin), Sertraline (Setrona).

• Adverse Effects: SSRIs as a class are associated with agitation, drowsiness, tremor, dry mouth, dizziness, headache, and sweating.

• Dental Implications:

  • Tramadol should not be co-prescribed with SSRIs due to the risk of serotonin toxicity.

  • Specific SSRIs like citalopram and escitalopram carry a risk of QT prolongation.

  • Fluoxetine and fluvoxamine inhibit the CYP3A4 enzyme, affecting the metabolism of other drugs.

Tricyclic Antidepressants (TCAs)

• Example Drugs: Amitriptyline (Endep), Nortriptyline (Allegron).

• Adverse Effects: TCAs commonly cause sedation, dry mouth, orthostatic hypotension, tremor, and dizziness.

• Dental Implications:

  • Using adrenaline with TCAs can have added sympathomimetic effects, increasing the risk of a hypertensive crisis.

Serotonin and Noradrenaline Reuptake Inhibitors (SNRIs)

• Example Drugs: Desvenlafaxine (Pristiq), Duloxetine (Tixol).

• Adverse Effects: SNRIs can cause dry mouth, sweating, dizziness, headache, and tremor. Orthostatic hypotension is an infrequent side effect.

• Dental Implications:

  • There is a risk of serotonin toxicity when SNRIs are taken with tramadol.

Other Antidepressants

This group includes various drugs with specific side effect profiles:

• Mianserin (Lumin): Causes sedation, dry mouth, dizziness, and vertigo.

• Mirtazepine (Axit): Causes sedation and weakness, and rarely, orthostatic hypotension or seizures.

• Moclobemide (Amira): Causes dry mouth, anxiety, dizziness, and headache.

• Reboxetine (Edronax): Causes dry mouth, sweating, orthostatic hypotension, headache, paraesthesia, and dizziness.

• Vortioxetine (Brintellix): Causes dry mouth and itch.

---

Overall Dental Implications Summary

• Drug Interactions:

  • Adrenaline: Use with caution in patients taking TCAs or MAOIs due to the risk of a hypertensive crisis.

  • Tramadol: Avoid prescribing with SSRIs, SNRIs, and MAOIs due to the risk of serotonin toxicity.

• Common Adverse Effects:

  • Dry Mouth: This is a very common side effect of many antidepressants, including TCAs, SSRIs, SNRIs, mianserin, moclobemide, reboxetine, and vortioxetine, increasing the risk of caries.

  • Orthostatic Hypotension: This is a risk with MAOIs, TCAs, reboxetine, and infrequently with SNRIs and mirtazepine, requiring caution when repositioning the patient.

.

Revised Summary of Antipsychotics for Dental Practice

This summary outlines the key aspects of antipsychotic medications, explicitly linking their side effects to the drugs that cause them and detailing specific considerations for dental management, based on the provided lecture notes.

---

Indications and Mechanism

• Indications: Antipsychotic drugs are used for acute and chronic psychosis and bipolar disorder to relieve symptoms like hallucinations and delusions.

• Mechanism of Action: The mechanism for the antipsychotic class is believed to be the blockade of dopaminergic transmission in the brain.

Adverse Drug Reactions (ADRs) Caused by Antipsychotics

• General Side Effects: Antipsychotics as a class can cause sedation, anxiety, agitation, orthostatic hypotension, and dry mouth.

• Extrapyramidal Side Effects (EPSE): A significant concern with the antipsychotic class is the risk of EPSE, which includes dystonia (abnormal facial muscle tone), akathisia (restlessness), and parkinsonism (e.g., tremor). For example, the document notes that haloperidol can cause tremors as an EPSE.

---

Dental Implications and Management

Critical Drug Interactions

• QT Prolongation: Certain antipsychotics can prolong the QT interval. The document specifically names amisulpride, droperidol, haloperidol, and ziprasidone as drugs carrying this risk.

• CYP3A4 Inhibitors: The metabolism of many antipsychotics can be affected by CYP3A4 inhibitors. Drugs mentioned include aripiprazole, brexpiprazole, cariprazine, haloperidol, lurasidone, quetiapine, and ziprasidone.

• CNS Depressants: The sedative effects of antipsychotics can be additive when used with other CNS depressants.

Management of Antipsychotic-Induced Adverse Effects

• Dry Mouth (Xerostomia): This is a common side effect of the antipsychotic class that increases caries risk. The document specifically notes that a patient on haloperidol complained of dry mouth.

• Orthostatic Hypotension: This is a known side effect of antipsychotics, requiring caution when repositioning the patient in the dental chair.

• EPSE: The motor effects caused by antipsychotics, such as tremor, can directly impair a patient’s ability to perform effective oral hygiene. Involuntary facial movements can also complicate dental procedures.

Patient Considerations

• It is important to assess the patient’s mental state, their ability to provide informed consent, and their likely level of cooperation.

• Patients taking antipsychotics may have an increased sensitivity to the stress of invasive procedures.

• Consider the need for additional support, shorter appointments, or alternative sedation methods to ensure patient comfort and safety.

Revised Summary of Drugs for Bipolar Disorder for Dental Practice

This summary outlines the pharmacological agents used to treat bipolar disorder, with a specific focus on lithium and its key implications for dental practice, based on the provided lecture notes.

---

Pharmacological Treatment

The management of bipolar disorder involves several classes of medication:

• Antipsychotics

• Antiepileptics (e.g., carbamazepine, lamotrigine, valproate)

• Lithium (Lithicarb, Quilonum SR)

This summary will focus on lithium, as it is the primary drug detailed in this specific section of the document.

Lithium

• Mechanism of Action: The exact mechanism of lithium is unknown, but it is thought to potentially inhibit dopamine release and enhance serotonin release.

• Adverse Drug Reactions (ADRs) Caused by Lithium: Lithium is associated with common side effects including a metallic taste, fatigue, headache, vertigo, tremor, acne, and psoriasis.

---

Dental Implications and Management of Lithium Therapy

Critical Drug Interactions with Lithium

• NSAIDs: A major interaction of concern is between lithium and non-steroidal anti-inflammatory drugs (NSAIDs). Prescribing NSAIDs must be done with extreme caution as they can reduce the renal excretion of lithium, leading to increased levels and a risk of lithium toxicity. Low-dose aspirin is generally considered safe.

• Tramadol: When prescribing for patients on lithium, caution is advised with tramadol due to the risk of serotonin toxicity.

Management of Lithium-Induced Adverse Effects

• Metallic Taste: The metallic taste caused by lithium is a common side effect that can alter the patient’s taste perception.

• Tremor and Fatigue: Tremor and fatigue, which are side effects of lithium, can make it difficult for the patient to maintain fine motor control for oral hygiene and may affect their ability to cooperate during long procedures.

Patient Communication and Care

• It is important to assess patients taking lithium for sedation, mental alertness, and their ability to provide informed consent.

• Scheduling shorter or more frequent appointments may be necessary to accommodate for side effects like fatigue.

Summary of Drugs for Anxiety & Sleep Disorders for Dental Practice

This summary outlines the pharmacological agents used for anxiety and sleep disorders, with a focus on their specific side effects and key implications for dental practice.

---

Non-Pharmacological Treatment

Before pharmacological intervention, non-drug treatments are considered first-line. These include Cognitive Behavioural Therapy (CBT) for both insomnia and anxiety, as well as practicing good sleep hygiene principles.

---

Pharmacological Treatments and Their Dental Implications

Benzodiazepines

• Examples: Diazepam (Valium), Alprazolam, Lorazepam, Midazolam.

• Note: These are typically used for short-term relief due to a high risk of dependence.

• Adverse Effects: Benzodiazepines as a class can cause drowsiness, oversedation, lightheadedness, ataxia (loss of coordination), and paradoxically, either dry mouth or hypersalivation (drooling).

• Dental Implications & Interactions:

  • The sedative effects of benzodiazepines are additive with other CNS depressants.

  • Specific interactions include:

    • Alprazolam: Itraconazole and ketoconazole can enhance its sedative and respiratory depressant effects.

    • Diazepam: Fluconazole can increase its adverse effects.

    • Midazolam: CYP3A4 inhibitors can enhance its sedative and respiratory depressant effects.

Non-amphetamine Psychostimulants

• Examples: Armodafinil (Nuvigil), Modafinil (Modafin).

• Adverse Effects: This class of drugs can cause dry mouth, headache, anxiety, palpitations, nervousness, dizziness, and hypertension.

Orexin Receptor Antagonists

• Examples: Lemborexant (Dayvigo), Suvorexant (Belsomra).

• Adverse Effects: This class of drugs is noted to cause headaches.

Other Drugs for Sleep

• Sedating Antihistamines (e.g., diphenhydramine, doxylamine):

  • Adverse Effects: These drugs can cause sedation, psychomotor impairment, dizziness, confusion, headache, and dry mouth.

• GABA Agonists (e.g., zolpidem, zopiclone):

  • Adverse Effects: Zopiclone (Imrest) is specifically noted to cause a taste disturbance (bitter), dry mouth, drowsiness, and impaired alertness the next morning.

  • Interactions: The effects of GABA agonists are additive with other CNS depressants.

• Melatonin (Circadin):

  • Adverse Effects: The document notes no dental-related adverse effects for melatonin.

---

Overall Dental Management Summary

• CNS Depression: Be aware of the increased risk of sedation when patients are taking benzodiazepines, sedating antihistamines, or GABA agonists, and avoid co-prescribing other CNS depressants.

• Dry Mouth: This is a common side effect, particularly with non-amphetamine psychostimulants, sedating antihistamines, and zopiclone, increasing the risk for caries and mucosal issues.

• Taste Disturbance: A notable bitter taste is specifically associated with zopiclone.

• Patient Management: Schedule appointments when patients are most alert, provide clear aftercare instructions, and emphasize meticulous oral hygiene to manage side effects like dry mouth.

Summary of Drugs for ADHD for Dental Practice

This summary outlines the pharmacological agents used to treat ADHD, with a specific focus on their side effects and key implications for dental practice.

---

Pharmacological Treatment

The primary pharmacological treatment for ADHD involves psychostimulants. Other non-stimulant drugs, such as atomoxetine and guanfacine, are also used.

---

Drug Classes and Their Dental Implications

Psychostimulants

• Examples: Dexamfetamine, Lisdexamfetamine (Vyvanse), Methylphenidate (Concerta).

• Adverse Effects: Psychostimulants as a class can cause dry mouth, anxiety, irritability, headache, dizziness, aggression, and palpitations. Infrequently, they may cause movement disorders or tics.

• Dental Implications: The document notes that there are no significant dental drug interactions for this class of medication. The main concern for dental practitioners is the high prevalence of dry mouth, which increases caries risk.

Atomoxetine

• Adverse Effects: Atomoxetine can cause dry mouth, dizziness, irritability, aggression, and temper tantrums. Infrequent side effects include palpitations and orthostatic hypotension.

• Dental Implications: Similar to psychostimulants, the document notes no significant dental drug interactions for atomoxetine. Management focuses on the oral health consequences of dry mouth.

Guanfacine

• Example: Guanfacine (Intuniv).

• Adverse Effects: Guanfacine is associated with drowsiness, dizziness, dry mouth, headache, hypotension, fatigue, and sedation. Fainting is an infrequent side effect.

• Dental Implications:

  • Drug Interactions: Unlike the other ADHD drugs, guanfacine has significant interactions. Its sedative effects are additive with other CNS depressants, and its metabolism can be affected by CYP3A4 inhibitors.

  • Side Effects: The sedative properties and risk of hypotension require care when managing the patient in the dental chair.

---

Overall Dental Management Summary

• Dry Mouth: This is the most consistent and important dental side effect across all three classes of ADHD medication (psychostimulants, atomoxetine, and guanfacine), necessitating a strong focus on caries prevention through oral hygiene education, regular recalls, and fluoride treatments.

• Behavioral and Sedative Effects: Behavioral side effects from psychostimulants and atomoxetine (e.g., anxiety, irritability) may affect patient cooperation. In contrast, the sedative effects of guanfacine may cause drowsiness during appointments.

• Drug Interactions: While psychostimulants and atomoxetine have no major dental interactions listed, clinicians must be aware of the interactions between guanfacine and other CNS depressants or CYP3A4 inhibitors.

This summary outlines the pharmacological agents used to treat various forms of substance dependence, their side effects, and key implications for dental practice, as detailed in your document.

---

Treatment for Alcohol Dependence

• Withdrawal Symptoms: The acute symptoms of alcohol withdrawal are typically managed with CNS depressants like benzodiazepines.

• Long-Term Treatment:

  • Acamprosate: The document notes no dental-related adverse effects for acamprosate.

  • Naltrexone: This drug interacts with opioids, and its adverse effects are typically transient.

  • Disulfiram: This drug can cause drowsiness and headache. It has a significant interaction with metronidazole, which should be avoided.

Treatment for Nicotine Dependence

• Bupropion: This medication can cause dry mouth, dizziness, agitation, anxiety, tremor, and headache.

• Nicotine Replacement Therapy (NRT): Adverse effects of NRT vary by delivery method and can include dizziness, headache, a burning-lip sensation (from mouth spray), hiccups, cough (from inhalation), and vivid dreams (from the 24-hour patch).

• Varenicline: Side effects of varenicline include headache, taste disturbance, abnormal dreams, and sleep disorders.

Treatment for Opioid Dependence

• Buprenorphine: The document notes that adverse effects of buprenorphine are not dental-related, but it interacts with opioids and ketoconazole.

• Methadone: A key dental consideration for methadone is its potential to cause QT prolongation, which can affect the use of other medications. Patients on methadone maintenance therapy often present with high rates of caries and periodontal disease.

• Naltrexone: This is also used for opioid dependence.

---

Dental Implications of Illicit Substance Abuse

The document also provides important information on the oral health effects of the substances themselves, which is distinct from the side effects of the treatment medications.

• Cannabis: Associated with poor oral and periodontal health. An acute dose combined with a local anesthetic containing adrenaline may prolong tachycardia. Chronic use is linked to oral leucoplakia, oral cancer, and oral candidiasis.

• Methamphetamine: Associated with poor oral hygiene, rampant caries (“meth mouth”), bruxism, and xerostomia. Local anesthetics with vasoconstrictors should be avoided when the patient is intoxicated.

• Cocaine: Associated with bruxism, clenching, and gingival erosions or ulceration.

• Opioids: Associated with rampant caries, periodontitis, and anxiety. Injectable use carries risks of blood-borne viruses and infective endocarditis.

---

General Dental Management

• “Doctor Shoppers”: Clinicians should be vigilant for patients seeking specific analgesics or anxiolytics and can refuse to prescribe if a request seems inappropriate.

• Pain Management: For patients in recovery from opioid dependence (e.g., on methadone), opioid analgesics should be avoided to prevent relapse; non-opioid analgesics are preferred.

• Coordinated Care: It is important to coordinate with the patient’s other healthcare providers for safe and effective management.